Access the full text.
Sign up today, get DeepDyve free for 14 days.
[Nanoparticles hold great potential for improving the drug delivery of anticancer drugs. However, this potential is not fully utilized, evident from the small number of clinically approved nanoparticles. Nanoparticle design is evolving in complexity, yet most experimental methods cannot keep up since they lack the proper resolution for accurate characterization and testing necessary for clinical approval. The computational approach can advance research from the laboratory to clinical applications by offering insights into various phenomena with precision inaccessible to the experimental methods. It can also significantly reduce the time for new design testing and the costs associated with the experimental approach. To fully assess nanoparticles’ efficacy, we need to consider a wide range of length and time scales. These scales include single atom resolution (for precise characterization of their physico-chemical properties), single cell scale (to assess nanoparticle-cell interactions and movement across the tissue), and whole tumour scale to evaluate their influence on the tumour. In this chapter, we present a Multiscale approach utilizing those scales with the focus on the role of the Molecular Dynamics Simulations.]
Published: Aug 12, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.